canertinib dihydrochloride has been researched along with midostaurin in 1 studies
Studies (canertinib dihydrochloride) | Trials (canertinib dihydrochloride) | Recent Studies (post-2010) (canertinib dihydrochloride) | Studies (midostaurin) | Trials (midostaurin) | Recent Studies (post-2010) (midostaurin) |
---|---|---|---|---|---|
31 | 13 | 6 | 491 | 36 | 286 |
Protein | Taxonomy | canertinib dihydrochloride (IC50) | midostaurin (IC50) |
---|---|---|---|
Aurora kinase A | Homo sapiens (human) | 0.08 | |
Macrophage colony-stimulating factor 1 receptor | Homo sapiens (human) | 0.142 | |
Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | 0.109 | |
Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.25 | |
Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | 0.1663 | |
Aspartyl/asparaginyl beta-hydroxylase | Homo sapiens (human) | 7.5767 | |
AP2-associated protein kinase 1 | Homo sapiens (human) | 0.2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Russu, WA; Shallal, HM | 1 |
1 other study(ies) available for canertinib dihydrochloride and midostaurin
Article | Year |
---|---|
Discovery, synthesis, and investigation of the antitumor activity of novel piperazinylpyrimidine derivatives.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Molecular Structure; Piperazines; Protein Kinase Inhibitors; Protein Kinases; Pyrimidines; Stereoisomerism; Structure-Activity Relationship | 2011 |